Smithfield Trust Company »

Relay Therapeutics shares owned by Smithfield Trust Company

Quarter-by-quarter ownership of Relay Therapeutics (RLAY) shares owned by Smithfield Trust Company from 13F filings

Historical chart of Smithfield Trust Company investment in Relay Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relay Therapeutics held by Smithfield Trust Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relay Therapeutics by Smithfield Trust Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $11k 1.0k 11.00

More positions owned by Smithfield Trust Company

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Vanguard Index Fds Small Cp Etf (VB)
Vanguard Intl Equity Index F Ftse Europe Etf (VGK)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Intl Equity Index F Ftse Pacific Etf (VPL)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard Whitehall Fds High Div Yld (VYM)
Microsoft Corporation (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)

View all positions for Smithfield Trust Company

Top funds holding Relay Therapeutics

Vanguard Group
T. Rowe Price Associates
Casdin Capital
Jpmorgan Chase & Co
Bellevue Group
BVF
Arrowpoint Asset Management
Norges Bank Investment Management
Boxer Capital
Jacobs Levy Equity Management
Alphabet
Dimensional Fund Advisors
Nextech Invest
Baker Bros. Advisors
Goldman Sachs Group

View all funds holding Relay Therapeutics